Clinical Trials
6 trialsNCT06788912 2026-06-01
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT06305754 2026-05-29
MK-2870-009
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT06824467 2026-05-29
TroFuse-022
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT05319730 2026-05-26
MK-3475-06B
Merck Sharp & Dohme LLC
Phase 1/2 Recruiting
NCT04568902 2025-10-23
Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
Eisai Inc.
Phase 1 Completed
NCT00719472 2017-05-15
RATE
Genentech, Inc.
Phase 3 Completed